Delivery Order SPE2DB20D2104-SPE2DB23FS18P
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,004.96, is for the delivery of Difluprednate 0.05% eye drops in 5 milliliter vials. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award, valued at $2,210.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% Eye Drop, 5mL, and has a completion date of May 11, 2023. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,680.85, is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This award from the Defense Logistics Agency (DLA) is a delivery order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Difluprednate 0.05% eye drops in 5 mL packaging, with a ceiling value of $2,286.72 and a performance period through February 23, 2023. This contract does not have a...
- This federal contract award, valued at $11,601.85, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of Difluprednate 0.05% eye drops in 5 ml bottles. This contract is a delivery order and has a firm fixed price pricing type, with a completion date of May 15, 2023. The contract was awarded on May 12, 2023 and does not have a set-aside designation, indicating open competition....
- This federal contract award, valued at $11,003.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product, with a completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The delivery order is for the supply of difluprednate 0.05% eye drops in 5 ml containers, with a ceiling value of $3,965.92 and a completion date of March 8, 2023. The contract was awarded on a full and open competition basis, without any set-aside designation....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,309.01 firm fixed-price contract is for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML, a pharmaceutical product. The contract has a completion date of June 7, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,114.56, is a Delivery Order issued by the Defense Logistics Agency (DLA) for the supply of DIFLUPREDNATE 0.05% EYE DROP 5ML. The contract has an ultimate completion date of January 13, 2025 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the Amerisourcebergen Corporation. The $5,003.35 contract is for the supply of Difluprednate 0.05% eye drops in 5 milliliter vials. The award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS18PDelivery Order
This contract award, valued at $3,179.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Difluprednate 0.05% eye drops in 5ml quantities. This is a firm-fixed price delivery order contract with a completion date of February 14, 2023. The award is not associated with any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively. These IDCs enable the efficient procurement of a wide range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 2/13/23 |